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Effect of acute and chronic metabolic acidosis on serum im-
munoreactive parathyroid hormone in man. The effects of acute and
chronic metabolic acidosis on serum immunoreactive parathyroid
hormone (iPTH) were studied. Acute metabolic acidosis induced
by administration of ammonium chloride (NH4CI) produced a
barely detectable increase in serum IPTH. Chronic NH4CI ad-
ministration produced a marked elevation of serum iPTH that was
well correlated with the magnitude of acid-induced hypercalciuria
but not with the degree of acidosis. Acetazolamide administration
produced an equivalent degree of acidosis, but hypercalciuria was
minimal and IPTH increased only marginally. Methionine ad-
ministration caused moderate hypercalciuria and a significant but
moderate increase in iPTH. Chronic NH4C1-induced acidosis
produced no hypercalciuria when dietary sodium intake was
rigidly restricted, and under these conditions serum iPTH
remained normal. When sodium intake was suddenly increased
while maintaining the acid load, hypercalciuria appeared and was
followed by progressive rise in serum iPTH equivalent to that
observed during chronic NH4CI-induced acidosis in subjects con-
suming salt ad lib. These results indicate that chronic acidosis
elevates iPTH mainly by producing hypercalciuria and that
acidosis itself is not a primary stimulus to PTH secretion.
Effet de l'acidose metabolique aigue et chronique sur Ia concentra-
tion sérique d'hormone parathyroIdienne immunoréactive chez
l'homme. Les eflets de l'acidose métabolique aiguë et chronique sur
Ia concentration sérique d'hormone parathyroidienne im-
munoréactive (iPTH) ont été étudiés. L'acidose metabolique aiguë
produite par l'administration de chlorure d'ammonium (NH4CI)
determine une augmentation de iPTH a peine detectable. L'ad-
ministration prolongee de NH4C1 produit une élévation impor-
tante de iPTH, élévation qui est bien corrClée avec l'ampleur de
l'hypercalciurie induite par Ia charge acide mais non corrélCe avec
l'importance de l'acidose. L'administration d'acétazolamide
produit une acidose d'importance équivalente mais l'hyper-
calciurie est minime et iPTH augmente trés peu. La méthionine
determine une hypercalciurie modérée et une augmentation signifi-
cative mais faible de iPTH. L'acidose chronique par NH4C1
n'entraine pas d'hypercalciurie quand une restriction sévère du'
sodium alimentaire est associée et alors iPTH demeure normale.
Quand l'apport de sodium est bruquement augmenté alors que Ia
charge acide est maintenue I'hypercalciurie apparaIt. Elle est suivie
d'une augmentation progressive de iPTH equivalente a celle
observée au cours de l'acidose chronique par NH4C1 chez des sujets
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ingérant du sd ad libitum. Ces résultats indiquent que l'acidose
chronique élCve iPTH surtout par l'intermédiaire de l'hyper-
calciurie et que l'acidose en elle-même n'est pas un stimulus
primaire de Ia secretion de PTLI.
A number of experimental observations indicate
that metabolic acidosis can affect parathyroid func-
tion. Depression of circulating immunoreactive
parathyroid hormone (iPTH) has been described as a
consequence of severe, acute metabolic acidosis in
sheep [1]. In contrast, preliminary observations sug-
gest that chronic metabolic acidosis increases iPTH
[2]. Hypercalciuria is a well-known consequence of
chronic metabolic acidosis [3], and in at least two
forms of hypercalciuria, idiopathic hypercalciuria
and hypercaliuria induced by furosemide administra-
tion, increased serum iPTH has been described [4, 5].
In renal tubular acidosis, acidosis and hypercalciuria
coexist, and increased iPTH has been described [6, 7].
This report details parathyroid response to acute and
chronic metabolic acidosis under controlled condi-
tions.
Methods
Subjects. AU experiments were performed on ten
normal, healthy, young men and women. In each, a
thorough medical history was obtained and a
physical examination was performed by one of us. In-
formed consent for the study was obtained.
Experimental design. 1) A cute metabolic acidosis.
Five normal subjects were studied. Each had been
fasting since the preceding midnight, and remained
fasting throughout the experiment. Experiments were
begun at 7:30 AM. To minimize urine collection er-
rors, each subject received an initial water load of 500
ml, followed by 250 ml hourly, to maintain urine
flow rate, throughout the experiment. Blood pH and
Pco2, serum total CO2 content, total and ionized
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calcium, magnesium, phosphorus, creatinine and im-
munoreactive parathyroid hormone (iPTH) were
measured during two one-hour control periods.
Urinary calcium and phosphorus excretion and
creatinine clearance were also measured during each
control period using one-hour timed urine collec-
tions. Each subject then received NH4C1, 1.5 to 1.75
mEq/kg of body wt, given orally over one hour, and
all measurements were repeated during six one-hour
experimental periods.
2) Chronic metabolic acidosis without sodium
restriction. Seven normal subjects were studied as
outpatients while ingesting their customary diet, ex-
cept that all subjects refrained from use of dairy
products and calcium-containing medication during
one week before and throughout the experiments.
Blood pH and Pco2, serum total CO2 content, total
calcium, ionized calcium, ultrafilterable calcium,
magnesium, phosphorus, creatinine, sodium, potas-
sium and iPTH were measured on three or four con-
secutive control days. Twenty-four-hour urine speci-
mens were also collected during each control day for
measurement of urinary calcium, sodium, potassium
and phosphorus excretion and 24-hr creatinine clear-
ance. Each subject then received either NH4C1 or
DL-methionine, 1.9 mEq/kg of body wt/24 hr given
in four divided doses, or acetazolamide, 750 mg/24
hr in three divided doses, for nine consecutive days.
For subjects receiving NH4CI all measurements were
repeated during each of the nine days of treatment.
For subjects receiving methionine and acetazolamide,
all measurements were repeated during the seventh,
eighth and ninth days of treatment.
3) Chronic metabolic acidosis with varying NaCI in-
take. Four normal men were studied according to the
chronic acidosis protocol except that dietary sodium
intake was restricted to below 20 mEq/24 hr begin-
ning on the first day of NH4C1 treatment. The sub-
jects were then studied on days 6, 7, 8 and 9 of com-
bined sodium restriction and NH4C1 loading. On day
10 sodium intake was abruptly increased to above
300 mEq/24 hr by administration of NaCl in tablet
form without other alterations in diet. Measurements
were then continued for nine days of combined
NH4CI and high NaCI intake (experimental days 10
to 18). Ultrafilterable calcium was measured through-
out the 18-day experiment to assess fractional excre-
tion of calcium; otherwise, all measurements were the
same as those during chronic acidosis on unrestricted
sodium intake. During pre-acidosis control periods, a
liberal sodium intake was encouraged so that the
filtered load of calcium would tend to exceed that
during acidosis periods.
4) Normal fractional excretion of calcium. In addi-
tion to the observations made during the control
periods of the preceding experiment (chronic
acidosis with varying NaCI intake), the fraction of
filtered calcium excreted was measured in three of the
four experimentsl subjects on 3 to 5 other occasions,
and in eight additional normal subjects on 13 occa-
sions. Sodium intake was kept lower than normal,
between 40 and 80 mEq/24 hr, to obtain a range of
values of low filtered loads. Twenty-four-hour urine
samples were collected for determination of calcium,
sodium and creatinine, and postabsorptive blood
samples were drawn between 7 and 9 AM at the con-
clusion of each urine collection, for determination of
ultrafilterable calcium and serum sodium and
creatinine. These studies were performed while sub-
jects were eating their normal diets but were consum-
ing no milk or dairy products.
Techniques of sample collection. Urine was col-
lected in polypropylene bottles containing 10 ml of
concentrated hydrochloric acid. In acute experi-
ments, urine collections were supervised directly by
the investigators. During chronic studies, subjects
were instructed in appropriate techniques of urine
collection; actual times of initiation and completion
of each sample were reported by the subjects, and all
values were computed to 24 hr. During acute experi-
ments, blood samples were drawn at the midpoint of
each clearance period. Blood samples for chronic ex-
periments were drawn between 7 and 9 AM at the con-
clusion of each urine collection while patients were in
the postabsorptive state. The tourniquet for
venipuncture was left in place no longer than 30 sec;
blood samples were not drawn until two minutes
after its release. For each determination of ionized or
ultrafilterable calcium, 5 ml of blood was collected in
vacutainer tubes, filled to capacity, and without
heparin, and centrifuged to separate red blood cells.
Serum for ionized calcium was drawn anaerobically
into a tuberculin syringe and used immediately for
measurements as described elsewhere [8, 9]. Samples
for ultrafilterable calcuim were drawn into 5-ml
syringes, under oil, and transferred to ultrafilter
cones (vide infra). In 20 preliminary experiments,
direct measurement showed no significant alteration
of either pH or Pco2 between the final serum sample
and original blood concentrations, in samples
prepared for either ionized or ultrafilterable calcuim
measurements. Blood and urine samples for total
calcium were diluted within 30 mm of collection us-
ing automatic dilutors in which samples contact parts
made only of tygon. For plasma phosphorus and
creatinine, and serum iPTH measurements, plasma
and serum were either diluted or frozen within one
hour. Capillary blood pH and Pco2 were measured
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on fingertip samples stored in sealed capillary tubes,
on ice, until used. Blood pH and Pco2 and serum
total CO2 content were measured within one hour.
Laboratory methods. Calcium concentration was
determined in serum and urine using atomic absorp-
tion spectrometry with a lithium-strontium diluent.
Samples were each diluted three times, and each dilu-
tion was analyzed separately. If the three dilutions
did not agree within 0.1 mg/l00 ml, continued dilu-
tions were made until three consecutive dilutions
agreed within this limit. Ionized serum calcium con-
centration was measured using a flow-through liquid
membrane electrode (Orion, Series 98), calibrated
with calcium chloride standards supplied by the
manufacturer, following methods detailed elsewhere
[8, 9]. For measurements, a tuberculin syringe com-
pletely filled with serum was mounted in a syringe
pump and the sample circulated through the
electrode. Replicate measurements of the sample
were within 0.1 mg/l00 ml; each sample was run in
triplicate and mean values were calculated. Subjects
were studied sequentially, so that on a given day only
one sample from an experimental subject was
studied. Preliminary studies of samples from 60 nor-
mal people showed a mean value of 4.88 mg/l00 ml
with a SD of 0.16 mg/100 ml. Ultrafilterable calcium
was determined on a 5-ml serum sample, prepared as
described in the preceding section, using a diaflow
membrane (Ultrafiltration Membrane Cones #2100
CF 50). Samples were kept under oil while in the filter
cone; pH and Pco2 were unchanged after transfer to
the ultrafilter.
Phosphorus and creatinine concentration of
plasma and urine were determined by autoanalyzer
methodology. Serum venous CO2 content was deter-
mined by microgasometry. Blood pH and Pco2 were
measured using a standard ultramicro apparatus.
Serum and urine magnesium were determined using
atomic absorption spectrometry. Sodium and potas-
sium were measured by flame photometry. Serum
iPTH was measured by radioimmunoassay, described
elsewhere [10—12]. Assay results are expressed in
tEq/ml of a standard, reference, hyperparathyroid
serum, with a normal range of 10 to 60. A polyvalent
antiserum containing both N-terminal and C-
terminal recognition sites was used; the predominent
specificity of the antiserum is for C-terminal frag-
ments [1]. Coefficient of variation of the assay is 8%
[10].
Results
A cute metabolic acidosis. Acute metabolic acidosis
induced by ingestion of NH4C1 had a minor effect
upon serum 1PTH (Fig. 1, Table 1). Serum iPTH con-
centration rose slightly but significantly (P < 0.001).
Ionized serum calcium concentration fell slightly but
significantly (P < 0.001). Serum phosphorus con-
centration and urinary phosphorus excretion rose
and tubular phosphorus reabsorption fell progres-
sively and significantly during the six acidosis periods
(P < 0.001), (Fig. 1, Table 1). No significant changes
occurred between control and acidosis periods in
blood Pco2, total serum calcium concentration,
creatinine clearance or urine calcium excretion rate.
Serum magnesium concentrations (not shown) also
failed to change.
Chronic metabolic acidosis without sodium restric-
tion. 1) Ammonium chloride (NH4CI). Induction of
chronic acidosis in three normal subjects increased
urine calcium excretion serum iPTH (Fig. 2, Table
2). The increase in iPTH was significant for each of
the subjects as well as for the group (Table 2). Serum
total calcium concentration fell in each subject, but
ionized calcium remained unchanged. Plasma
phosphorus concentration, creatinine clearance and
the ratio of phosphate to creatinine clearance did not
change significantly (Table 3). Serum magnesium
concentration fell slightly, but significantly, in each
subject (Table 4).
Acidosis appeared during the first day of NH4C1
administration (venous total C02, 20 1 m
moles/liter) and was as severe on the first day as dur-
ing days 7, 8 and 9 acid loading (Table 3). During the
intervening days, it was nearly constant (range, 19
1 to 20 1 m moles/liter). Urine calcium excretion
rose more slowly, as did serum iPTH (Fig. 2). The
poor temporal correlation between acidosis and
iPTH is reflected by low correlation coefficients
between either blood H or venous total CO2 content
and iPTH (r = 0.24 and 0.29, respectively; P. not
significant [NS]). On the other hand urine calcium ex-
cretion and iPTH were well correlated (r = 0.48, P <
0.02) reflecting the synchronicity of their gradual in-
creases. A more exact estimate of temporal correla-
tion, or its absence, can be obtained by calculating
the partial correlation coefficient for iPTH and urine
calcium excretion excluding mathematically any con-
tribution of acidosis [13] and then repeating the
procedure but removing the effects of hypercalciuria,
leaving only those of acidosis. This procedure com-
pensates for the overlap caused by the small increase
in calcium excretion during the first day or two of
acid loading, the period in which acidosis appeared.
The partial correlation coefficient for iPTH and urine
calcium excretion was 0.44 (P < 0.05) compared to
0.14, (P. NS) for iPTH and degree of acidosis,
whether the latter is measured by blood H or venous
Fig. 1. Effects of acute NH4CI acidosis on
calcium, phosphorus and serum IPTH in
five normal subjects. Peak acidosis oc-
curred 100 mm after NH4CI ingestion (1.9
mEq/kg of body wt). Serum phosphorus
and urinary phosphorus excretion rose
and tubular phosphorus reabsorption fell.
Serum iPTH rose slightly and transiently,
and the serum ionized calcium concentra-
tion fell slightly. Symbols: 0 = subject 1,
25 yr, F; • = subject 2, 30 yr, M; LII =
subject 3, 26 yr, M; = subject 4, 30 yr,
M; A = subject 5, 30 yr, F.
total CO2 content, showing that the temporal dis-
sociation between acidosis and iPTH was virtually
complete.
All three subjects lost weight due to the transient
diuretic effect of NH4C1 (Table 4). Serum sodium and
potassium concentrations were unchanged by acido-
sis; urine potassium excretion fell significantly. Urine
sodium excretion fell during days 7, 8 and 9 of acido-
sis reflecting a preceding diuresis, but the change was
significant in only one subject (Table 4).
2) Met hionine. The effects of methionine ad-
ministration were similar to those of NH4C1; in each
subject, serum iPTH and urinary calcium excretion
rose significantly (Fig. 3, Table 2), whereas no signifi-
cant changes occurred in serum total calcium, ionized
calcium, magnesium (not shown), phosphorus,
creatinine clearance, urinary phosphorus excretion,
or fraction excretion of phosphorus (Tables 2 and 3).
Elevation of serum iPTH level was as closely cor-
related with the development of hypercalciuria dur-
ing methionine acidosis as it was during NH4CI
acidosis (r = 0.51, P < 0.01). However, in contrast to
ammonium chloride acidosis, it was not possible to
evaluate the individual correlations between urine
calcium excretion or serum proton concentration and
PTH using partial correlation coefficients because no
observations were made during the first six days of
methionine administration, Since acidosis, hyper-
calciuria and high serum iPTH, all absent during con-
trol periods, were fully established by day 7, they
must appear to be correlated with one another to an
equivalent degree.
3) Acetazolamide. The response of serum iPTH to
acidosis was slight and variable; iPTH increased in
two of the four subjects and in the other two it
remained constant (Fig. 3, Table 2). Urinary calcium
Control Acidosisb
Serum iPTH, ,.iEq/ml 40 4 53 2
Serum ionized calcium, mg/lOOml 4.9 0.1 4.6 0. 1C
Plasma phosphorus, mg/IOU ml 3.4 0.1 4.2 0.lc
Tubular phosphorus reabsorption,% 95 0.5 88 l
Blood Pco2, mm Hg 38 0.2 38 0.3
Serum calcium, mg/IOU ml 9.6 0.1 9.6 + 0.1
Creatinine clearance, mI/mm 127 7 131 5
Urine calcium excretion, mg/mm 189 18 194 14
a All data expressed as mean
Acidosis periods 3 and 4 for serum iPTH and ionized calcium;
acidosis periods 3, 4, 5 and 6 for plasma phosphorus, tubular
phosphorus reabsorption, blood Pco2, serum calcium concentra-
tion, creatinine clearance and urine calcium excretion.
Differs from control, P < 0.001.
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Table 1. Effects of acute NH4CI acidosis on calcium phosphorus,
and serum iPTH in five normal subjectsa
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Fig 2. Effects of chronic NH4CI administration on calcium and
IPTH in three normal subjects. Values for control periods are
means + 1 SEM for three control days in three subjects. Serum total
and ionized calcium and iPTH are shown as daily means I SEM
during acidosis; calcium excretion data are pooled 72-hr means. In-
dividual data for control periods and days 7, 8 and 9 of acidosis are
detailed in Table 2.
excretion increased to some extent in each of the four
subjects; however, the magnitude of the increase was
small in comparison to that observed with NH4C1 or
methionine administration. The mean increase for
the four subjects was statistically significant (Table
2). Serum total calcium, ionized calcium, and
phosphorus concentrations and creatinine clearance
and fractional excretion of phosphorus all remained
constant (Table 2 and 3). Blood Pco2 fell more
markedly in the acetazolamide-treated subjects than
in NH4C1- or methionine-treated subjects: neverthe-
less, acidosis was equivalent with acetazolamide (H
43.3 nEq/liter) and with methionine (H = 42.7
nEq/liter) administration, and both were equivalent
to that observed with ammonium chloride (43.9 nEq/
liter) (Table 3).
Chronic acidosis with varying sodium intake. When
sodium intake was reduced, urinary calcium failed to
increase in the four normal subjects studied even
though NH4CI was administered for nine consecutive
days and venous total CO2 content fell to the same
level observed in the three subjects given NH4C1
without restriction of sodium intake (Fig. 4, Table 5).
Despite acidosis, serum iPTH did not rise. Serum
total calcium fell in each subject. The change was
significant in only two subjects (Table 5), but the fall
for all four subjects was significant (9.72 0.09 vs.
9.47 0.08 mg/l00 ml; t = 3.350, P < 0.05). The
slight fall in total calcium concentration occurred
despite stable or rising serum albumin levels (Table
5). Serum magnesium concentration did not change.
Increase in sodium intake from NaCl tablets, with
fixed acid intake, resulted in marked natriuresis
(Table 5) and sustained hypercalciuria (Fig. 4).
Serum iPTH rose progressively in each subject attain-
ing an average level of 105 2 z Eq/rn 1, significantly
above control (P < 0.00 1). Although ionized calcium
remained stable (Fig. 4, Table 5), total calcium fell in
two subjects despite stable albumin concentrations
(Table 5). The change for the entire group, compar-
ing control to the last six high salt periods, was more
impressive than during low salt periods (9.72 0.09
vs. 9.35 0.062 mg/lOO ml, P < 0,02). Total calcium
means for the group fell below the low salt mean dur-
ing all nine high salt periods because of subjects 2 and
10 (Table 5); but the difference between group mean
serum calcium concentrations during low and high
salt periods was not significant.
Despite a fixed acid load, venous CO2 content rose
during high sodium intake, presumably because acid
excretion increased. This may have been due partly to
Time, days
Fig 3. Effects of chronic meihionine and acetazolamide administra-
tion on calcium and IPTH. See legend to Fig. 2.
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Table 2. Effects of chronic metabolic acidosis on calcium excretion and serum iPTH in normal subjects8
.
Subject No.,
N of experiments,
sex, age
Serum calcium
mg/lOO ml
Ionized calcium
mg/100 ml
Serum PTH
mEq/mI
Urine calcium
mg/24 hr
Control' Acidosis Control Acidosis Control Acidosis Control Acidosis
Ammonium chloride
2, M, 30 9.68 + 0.1 9.10 Q•10d 4.63 0.3 4.68 0.1 45 7 106 14d 122 9 224 24d
6, M, 30 9.65 0.06 9.11 0.028 4.43 0.17 4.53 0.05 49 9 118 28 177 25 268 + 50
1, F, 25
Group mean
dc
9.58 0.04 9.11 0.05
9.64 0.03 9.11 + 0.01
—0.53 0.O3
4.61 0.35 4.61 0.12
4.56 0.04 4.61 0.04
0.05 0.03
27 1 146 188
40 7 123 l283 lS
122 + 20 250 50d
140 18 247 l3
107 9!
Methionine
2, 2, M, 30 9.68 + 0.05 9.47 0.09 4.95 0.09 4.88 0.16 36 I 65 + 48 92 16 253 25
7, M, 24 9.54 0.02 9.92 0•06d 4.62 + 0.07 4.60 0.06 39 2 62 II 140 + 4 228 l3
2,3, M, 30 9.61 9.68+0.04 4.57 5.17±0.06 39±1 78 2 118+19 230+ 88
3, M, 26 9.83 0.01 9.80 0.08 4.72 0.22 5.09 + 0.06 38 2 70 3 149 18 202 38
Group mean
d
9.67 0.15 9.71 0.21
0.04+0.11
4.72 0.08 4.93 0.15
0.21 0.15
37.8 2 68 38
31 2.l
126 7 228 1 i
107 + 20d
Acetazolamide
8, M, 31 9.43 0.04 9.55 + 0.07 4.69 + 0.08 4.59 0.04 21 I 31 + 4 110 12 171 + 18d
2, 4, M, 30 9.27 0.03 9.64 0.078 4.66 + 0.17 4.49 0.16 38 2 54 5d 107 + 10 190 i8
9, F, 24 9.53 0.06 9.21 + 006d 4.72 + 0.29 4.82 + 0.12 24 1 54 + 2 63 + 4 140 + 3!
3, 2, M, 26 9.95 0.03 9.35 0.06 4.78 0.12 4.91 0.02 36 0.1 36 0.1 221 + 44 253 + 50
Group mean 9.54 0.14 9.48 0.09 4.71 0.02 4.70 0.10 29.8 4 43.8 6.4 125 + 34 189 24
d —0.06 0.16 —0.01 0.07 14 6 64 + 10d
Each subject was studied only once during any one type of acidosis; all values are therefore individual experiments.
Control and acidosis values are means (+ I SEM) of 3 or 4 control days 7, 8 and 9 of acidosis.
Mean (± I SEM) of differences between control and acidosis periods; P values, indicated by footnote symbols refer to significance of differ-
ence from zero.
d Differs from control, P < 0.05.
Differs from control, P < 0.01.
Differs from control, P < 0.005.
Table 3. Degree of acidosis, creatinine clearance, and fractional excretion of phosphate during chronic acid administration
Type of acidosis
NH4CI
(3 subjects)
Methionine
(4 subjects)
Acetazolamide
(4 subjects)
Blood proton conc, nEq/liler C8 39.6 + 1.2
A8 43.9 18b
39.8 0.4
42.7 1.91
39.8 0.3
43.3 06b
Blood Pco2, mm Hg C 41 0.3
A 36 + 1b
38 + 1
36 1
39 0.8
30 04b
Venous total CO2. mmoles/liter C 27 1
A 22 2"
27.3 1
23 1
27 I
18 02b
Plasma phosphate,mg/iO0ml C 3.6
A 3.5 0.2
3.7
0.3
3.4 +0.1
3.5 0.2
Creatinine clearance, mI/mm C 108 12
A 124 + 14
122 14
128 15
123 5
109 8
Cphos/Ccreatd C 14 2
A 15
1 1
15
C, means (± I SEM) of three or four control days; A, means (± I SEM) of 7, 8 and 9 of acidosis.
"Differs from control, P < 0.001.
Differs from control, P < 0.05.
d Phosphate clearance divided by creatinine clearance.
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Table 4. Serum and urine sodium and potassium, and body weight during chronic NH4CI administration
Subject Nos. Group mean db
1 (F, 25 yr) 2 (M, 30 yr) 6 (M, 30 yr)
Serumsodium
mEq/liter
C
A
141± 1
140 + 1
140±2
139 2
139±2
140 2
140±2
140 2 0
Serum potassium
mEq//iter
C
A
3.8 0.!
3.6 0.2
3.9 0.2
3.9 + 0.2
4.1 + 0.1
4.1 + 0.2
3.9 + 0.2
3.8 + 0.3 —0.1 0.3
Urinesodium
mEq/24hr
C
A
109+12
59±7
113
109±6
97±4
81±5
106± 9
83±8 —23± 1.4
Urine potassium
mEq/24 hr
C
A
52 + 2.3
32 + 3C
45 3
28 4d
63 15
30 6
53 5
30 2c —23 5d
Body wt
kg
C
A
43 0.3
42 0.3"
78 0.3
77 + 0.3"
77 0.3
76 0.3
66 6
65 6
—1.3 0.13c
Serum magnesium
mg/lOOm!
C
A
2.05 + 0.01
1.88 + 0.02
2.15 + 0.01
1.90 0.006e
2.13 0.03
1.9 + 0.OIC
2.11 0.02
1.92 0.02
—.19 + 0.02"
Control and acidosis values are means (± 1 SEM) of three or four control days and days 7, 8 and 9 of acidosis.
Mean (+ 1 SEM) of differences between control and acidosis periods, P values refer to significance of difference from zero.
Differs from control P < 0.02.
d Differs from control P < 0.05.
Differs from control P < 0.005.
increased phosphorus excretion (control, 982 8;
low salt, 948 25; last six high salt periods, 995 20;
all in mg/24 hr) during high as compared to low
sodium intake periods, or to increased glomerular
filtration rate (GFR) (Table 6). Ammonia excretion,
not measured, may also have risen. Despite elevated
iPTH levels, fractional excretion of phosphate did
not rise (Table 5).
Variations in sodium intake altered calcuim excre-
tion mainly by changing overall tubular reabsorp-
tion. During nonacidotic periods, calcium excretion
was nearly independent of filtered load (Fig. 5).Dur-
ing NH4CI loading with very low sodium intake,
average calcium excretion rates were unchanged from
control periods but the filtered load of calcium was
lower than control measurements from the four acid-
loaded subjects because GFR was reduced, over-
balancing a slight rise in ultrafilterable calcium
(Table 6). These data suggest a slight reduction of
tubular calcium reabsorption was present. Additional
evidence for such a reduction is that the filtered load
during combined NH4C1, low salt periods was equal
to that during measurements of calcium excretion
performed without acidosis but with mild dietary
sodium restriction (low NaC1 control, Table 6),
whereas calcium excretion was much higher. During
combined volume expansion and acidosis, the
average filtered load was below that of the high NaCI
control period because GFR was lower, but calcium
excretion was far higher so that fractional excretion
of calcium was therefore much increased, The fact
that altered fractional excretion rather than increased
filtered load was the main reason for hypercalciuria
strongly suggests that renal, as opposed to extrarenal,
factors such as variation in gastrointestinal calcium
absorption were responsible.
Discussion
A cute acidosis. Hyperphosphatemia and phospha-
tuna occurred in each subject during acute metabolic
acidosis. This transient phenomenon, well docu-
mented in previous experiments [14], probably re-
sulted from mobilization of phosphorus from bone
or intracellular stores, since subjects were fasting
throughout the period of observation.
Mild hyperphosphatemia could have caused the
slight increases in serum iPTH that were observed.
Modest hyperphosphatemia due to oral ingestion of
phosphate can increase serum PTH in normal sub-
jects [15], and although serum phosphorus increased
less in the present experiments than in those employ-
ing oral administration of phosphate, the increases in
iPTH during acute acidosis were also smaller.
Hyperphosphatemia is thought to stimulate PTH
secretion by lowering ionized serum calcium [15, 16].
Although they were slight, the decreases in ionized
calcium that were observed as serum phosphorus rose
may explain the iPTH increase. Equivalent decreases
0.35 and 0.25 mg/l00 ml were observed by Reiss et al
in two subjects given phosphate orally [15], and were
associated with a rise in iPTH of 20 and 70 mEq/ml,
respectively. In the present experiments, serum iPTH
increased by only 13 zEq/ml by the same immunoas-
say.
It is of interest that ionized serum calcium con-
centration fell at all during acute NH4CI acidosis, as
H competes with Ca for binding sites on serum
proteins and part of nonionized calcium is complexed
with HC03, which fell [17]. Presumably, the effects
of hyperphosphatemia outweighed those of acidosis,
although the details of their interaction were not ex-
plored in these studies. Artifacts due to a fall in serum
Pco2 during measurement of ionized calcium are un-
likely, as preliminary studies showed that our sample
handling methods did not lead to escape of CO2 from
serum (Methods). During chronic acidosis, serum
phosphorus concentration did not increase, and
serum ionized calcium concentration either rose
slightly or remained constant (Tables 2 and 5).
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Presumably, these changes reflect the effects of
acidosis unencumbered by hyperphosphatemia.
Urine calcium excretion did not change during
acute acidosis, a finding compatible with our own
chronic studies as well as the observations of others.
During our chronic NH4C1 administration experi-
ments, urine calcium excretion rose progressively
during the first six days of acidosis. In other in-
vestigations designed to study the relationship of
acidosis and hypercalciuria in detail [18], hyper-
calciuria appeared in parallel with ammonia adapta-
tion, a process requiring about four days.
Chronic acidosis. 1) Cause of increased serum iPTH.
One explanation for the increase in iPTH with
chronic, as opposed to acute, acidosis is that acidosis
itself can elevate IPTH, given sufficient time.
However, a number of observations are compatible
with this explanation. Serum iPTH increases promptly
in response to hypocalcemia, its principal physio-
logical stimulus, generally rising within minutes to
hours [15, 16]. If acidosis is a specific stimulus to
PTH secretion, it is difficult to understand why the
600
Fig 4. Effects of varying NaCJ intake on calcium and jPTH during
stable, chronic NI-14C1 acidosis. During low NaCI intake, chronic
NHCI administration (1.9 mEq/kg of body wt/24 hr) failed
to produce hypercalciuria of increased serum iPTH concen-
tration. Addition of NaCI, at a fixed acid intake, was followed
by hypercalciuria and progressive elevation of serum iPTH con-
centration. Total serum calcium concentration was below control
levels during all chronic acidosis periods; ionized calcium con-
centration rose slightly, but the increase was statistically insignifi-
cant. Urine calcium excretion and total and ionized serum calcium
are shown as means (± 1 SEM) for all four subjects; serum PTH
concentrations are shown individually. Symbols:• = subject 2, 30
yr, M; A = subject 4, 30 yr, M; A = subject 10, 30 yr, M; 0 =
subject 8, 31 yr, M.
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calcium reabsorption is evident, however, because calcium excre-
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normal subjects (s). Calcium excretion during combined NH4CI
and high NaCI administration (0) was very elevated despite
filtered load being similar to nonacidotic control periods (Table 6),
indicating a reduction of tubular calcium reabsorption.
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effect is exerted so slowly. Serum PTH did not attain
its maximal level until the fifth day of NH4CI ad-
ministration (Fig. 2), yet acidosis was fully estab-
lished by the first day. During methionine adminis-
tration, PTH was still rising by day 9, although
acidosis was present from the first day of treatment.
On the other hand, changes in urinary calcium ex-
cretion were closely associated with changes in serum
iPTH. Serum iPTH and urine calcium excretion were
both high during administration of NH4C1 and
methionine and both were low during acetazolamide
administration, During chronic NH4CI acidosis, the
correlation between hypercalciuria and hyper-
parathyroidism, judged by partial correlation coeffi-
cients, was excellent whereas the correlation between
acidosis and hyperparathyroidism was insignificant.
These observations suggested that hypercalciuria,
not chronic acidosis elevated serum iPTH, and led
us to test this hypothesis by using variation in sodium
intake to alter calcium excretion during chronic,
sustained acid loading. With sodium restriction,
chronic acidosis resulting from NH4C1 administra-
tion produced neither its characteristic hypercalciuria
nor elevated serum PTH levels. Sodium chloride sup-
plements permitted hypercalciuria to occur,
whereupon serum iPTH rose progressively to levels
similar to those reached when NH4C1 was ad-
ministered to unrestricted subjects, even though
acidosis, judged by venous CO2 content, was less
marked than under conditions of sodium restriction.
These experiments support the interpretation that
hypercalciuria rather than acidosis is responsible for
increased serum iPTH, but other possible
mechanisms must be considered. Acidosis could
decrease or increase the rate of PTH metabolism.
There are no data describing the effects of acidosis on
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Table 5. Effects of chronic amonium chloride acidosis during low and high sodium dietso
Subject Nos.
2 (M, 30 yr) 4 (M, 30 yr) 10 (M, 30 yr) 8 (M, 31 yr)
Serum calcium C 9.7 + 0.03 10 0.2 9.8 0.1 9.2 0.1
mg/lOOm! L
H
9.6 0.049.5 0.l 9.6 0.03'9.7 + 0.03' 9.6 0.03b9.3 + 0.lC 9.0 + 0.29.0 004b
Ionized calcium C 4.5 0.1 4.6 0.1 4.8 0.1 4.6 0.2
mg/lOOm! L
H
4.6 0.1
4.7 + 0.1
4.6 + 0.1
5.0 OP
4.8 0.1
4.6 + 0.1
4.8 + 0.1
4.7 + 0.1
Serum albumin C 5.1 0.1 4.8 0.4 4.7 + 0.1 4.6 0.3
g/lOOm! L
H
5.1 0.3
4.9 + 0.1
4.9 0.2
5.1 + 0.1
5.0 0.10
4.7 0.10
4.9 + 0.3
4.6 0.1
Serum magnesium C 2.05 + 0,01 2.13 0.03 2.11 + 0.02 2.15 0.01
mg/lOOm! L
H
2.10 0.02
2.10 0.02
2.11 0.02
2.12 + 0.02
2.13 + 0.03
2.12 + 0.02
2.12 0.02
2.14 0.01
Total venous CO2 C 24 0.3 25 0.4 29 + 0.3 26 I
mmoles/!iter L
H
19 0.8d
23 10
22 + 0,4d
22 0.40
21 id
23 + I
19 + I"
22 ie
Urine calcium C 177 12 181 8 172 10 162 + 3
mg/24 hr L
H
160 10
258
181 + 5
365 26"
184 17
354 15"'
176 + 11
340+ 1521.1
Urine sodium C
L
H
184 + 51
2O±6d
370 33b,f
161 12
46+8"
308 + l9"'
203 + 27
17+2"
328 170.1
135 13
12±2"
483 + 33"
Plasma phosphate C 3.5 0.4 3.5 0.3 3.5 0.3 3.6 0.2
mg/lOOm! L
H
3.5 0.3
3.4 + 0.2
3.6 0.3
3.5 0.3
3.5 + 0.3
3.4 + 0.3
3.6 0.3
3.4 0.2
Cphos/Ccreat C 13 2 13 + I 15 + I 15 2
% L
H
11±1
15±3
12±1
13±1
14±1
14±2
14+1
14±1
a All data expressed as means I SEM. C, mean of three control periods; L, mean of last four low salt, acidosis periods; H, mean of lasi
six high salt, acidosis periods.
10 Differs from control, P < 0.05.
Differs from control, P < 0.02.
"Differs from control, P < 0.01.
Differs from low salt, P < 0.05.
Differs from low salt, P < 0.01.
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Table 6. Excretion and filtered load of calcium during chronic NH4CI acidosis, with varying NaCI intakes
Low NaCI
control
High NaCI
control
NH4CI +
low NaCI
NH4CI +
high NaCl
Serum ultrafilterable
calcium 5.4 0.2 5.4 * 0.3 5.6 + 0.3 5.6 0.3
mg/lOO ml
Creatinine clearance 103 * 10 128 + II 102 + 8 115 + 12
mi/mm
Filtered load of calcium 5.5 0.2 7.0 0.2 5.7 + 0.3 6.4 + 0.2
mg/mm
Urine calcium excretion 118 4 165 + 9 181 5 356 + 17
mg/24 hr
All values are means 1 SEM. Low NaCI control data were derived from the study of three of the four experimental subjects (all but
subject 12, Table 5) and eight other normals; sodium intake was 40 to 80 mEq/24 hr (Methods). High NaCI data represent the three
pre-acidosis control periods for the four acid-treated subjects; dietary sodium intake was increased to 120 to 200 mEq/24 hr, in an
attempt to obtain filtered loads of calcium above those expected during combined treatment with low NaCl and NH4CI.
PTH metabolism, although the complexity of cir-
culating IPTH makes their alteration a plausible fac-
tor in our studies [11, 19,20]. Preliminary studies [21]
suggest that acidosis may increase bone and depress
renal response to PTH, the latter provoking a com-
pensatory increase in serum iPTH to preserve normal
renal handling of phosphorus as well as calcium.
Neither altered metabolism nor depressed renal
effects of PTH could explain the failure of chronic
acidosis to raise iPTH during salt depletion, although
either could account for increased iPTH during
chronic acidosis on an uncontrolled sodium intake.
The quantitative contribution of extracellular fluid
(ECF) volume expansion from increased NaCI intake
to increased iPTH in the critical experiments employ-
ing variation of NaCI intake during chronic NH4CI
acidosis cannot be precisely defined because the
direct effects of volume expansion on iPTH have not
been as yet fully explored. Knox et al [22] have
documented the failure of hyperoncotic albumin
ECF expansion to increase serum iPTH in dogs,
provided the ionized calcium concentration of the
albumin solution was raised to that of normal dog
plasma before its administration to prevent the
albumin from lowering plasma ionized calcium. In
addition, Epstein et al [23] have shown that relative
central hypervolemia induced by water immersion to
the neck, which results in natriuresis equivalent to the
i.v. infusion of 2 liters of saline, causes no changes in
iPTH.
2) Cause of hypercalciuria. The mechanism of
hypercalciuria during chronic acidosis also has not
been fully established, but impressive evidence sug-
gests it results from a primary decrease in renal
tubular calcium reabsorption. Lemann, Litzow and
Lennon observed elevated calcium excretion and
reduced fractional calcium reabsorption during
chronic acid loading despite an increased filtered load
of calcium [18]. Our results are equivalent to theirs in
showing depressed fractional calàium reabsorption,
although they are not as definitive because the filtered
load was not reduced compared to control levels, and
our measurements were based upon 24-hr averages
rather than acute clearances. Acid retention rather
than reduction of ECF pH seems to be the critical
stimulus to reduced calcium reabsorption as calcium
excretion does not rise until acidosis has been present
for at least a few days and then remains elevated
several days after acid administration ceases, a time
when blood pH has returned to normal but a signifi-
cant fraction of retained acid still remains to be ex-
creted [18]. The basic mechanisms by which chronic
acid loading reduces tubular calcium reabsorption
are unknown but its delayed onset and cessation and
close correlation with ammonia adaptation suggest
that hypercalciuria results from some alteration of
renal cellular metabolism. Conceivably this alteration
depresses renal response to iPTH [21], and thereby
blunts the calcium-conserving action of that hor-
mone.
Failure of acetazolamide to evoke hypercalciuria
despite producing acidosis is probably due, in
part, to its effects upon renal cyclic adenosine
monophosphate (AMP). In the rat, acetazolamide
administration increases renal cortical adenylate
cyclase activity and cyclic AMP production, and
causes phosphaturia, actions similar to those of PTH
[24]. As PTH causes calcium conservation, acting via
cyclic AMP [25], it is not surprising that
acetazolamide administration to dogs depresses prox-
imal tubule calcium reabsorption but fails to produce
calciuria, as the distal nephron can increase its reab-
sorption rate in response to increased delivery [26].
Presumably the development of hypercalciuria re-
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quires a depression of distal as well as proximal reab-
sorption, or at least a depression of proximal reab-
sorption without full distal compensation, conditions
which acetazolamide does not produce.
3) Stimulus to PTH secretion. How hypercalciuria
might increase serum iPTH is unclear, but there is a
suggestion that a fall in serum calcium concentration
may be involved. Chronic NH4C1 loading, the most
potent stimulus to hypercalciuria and hyper-
parathyroidism, resulted in a fall in total serum
calcium despite normal ionized calcium concentra-
tions. To some extent this must be an effect of
acidosis itself, as it occurred during low sodium in-
take when hypercalciuria was absent. But hyper-
calciuria may lower calcium further, as total calcium
decreased suggestively during high sodium periods
even though serum albumin remained stable. Perhaps
reduction of total and ionized calcium promotes PTH
release, and PTH returns ionized calcium to normal
rapidly enough so that only closely spaced sequential
measurements could have detected the initial fall.
Our own data cannot test this hypothesis. Serum
magnesium concentration fell during chronic NH4C1
loading with uncontrolled sodium intake (Table 4).
This could increase serum PTH, as depressed
magnesium concentration stimulates PTH secretion
in vitro [27J. However, a fall in serum magnesium was
not observed during experiments with controlled
sodium intake, yet iPTH rose; this suggests the con-
tribution of alterations in serum magnesium are
probably not an adequate explanation for our obser-
vation.
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